Participants 34 87 7
long-term exogenous subclinical hyperthyroid patients
Participants 687 814 7
25 patients with a history of differentiated thyroid carcinoma on long-term TSH-suppressive levothyroxine (l-T(4)) substitution
Participants 930 963 5
dditionally 40 euthyroid controls
